The Case Report of Newborn Prenatally infected by Human Immunodeficiency Virus in Republic of Korea

다국어 초록 (Multilingual Abstract)

Trans-placental neonatal human immunodeficiency virus (HIV) infection is common in Africa; however, it is not yet reported in the Republic of Korea. With the increasing incidence of HIV infection, especially in the reproductive age group, the risk of the vertical transmission of HIV is also increasing. We report the first case of HIV infection acquired in-utero in a newborn in Korea. The baby is growing well with normal development.

참고문헌 (Reference)

1 박종연, "Ten years of experience in the prevention of mother-to-child human immunodeficiency virus transmission in a university teaching hospital" 대한소아청소년과학회 57 (57): 117-124, 2014

2 Semrau K, "Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding" 47 : 320-328, 2008

3 Kuhn L, "Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial" 12 : 521-530, 2012

4 Connor EM, "Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group" 331 : 1173-1180, 1994

5 US Department of Health and Human Services, AIDSinfo, "Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States" National Institutes of Health

6 The Working Group on Mother-To-Child Transmission of HIV, "Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies" 8 : 506-510, 1995

7 Bandura A, "Preventing AIDS: theories and methods of behavioral interventions" Springer 25-59, 1994

8 Sperling RS, "Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group" 335 : 1621-1629, 1996

9 Garcia PM, "Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission" 341 : 394-402, 1999

10 Fitzgerald F, "Development of antiretroviral resistance in children with HIV in low- and middle-income countries" 207 (207): S85-92, 2013

11 Cooper ER, "Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission" 29 : 484-494, 2002

12 Marinda E, "Child mortality according to maternal and infant HIV status in Zimbabwe" 26 : 519-526, 2007

13 Lewis P, "Cell-free human immunodeficiency virus type 1 in breast milk" 177 : 34-39, 1998

14 Siegel JM, "AIDS diagnosis and depression in the Multicenter AIDS Cohort Study: the ameliorating impact of pet ownership" 11 : 157-170, 1999